Menu
Currency
GWAS Study

Genome-wide significant risk loci for mood disorders in the Old Order Amish founder population.

Humphries EM, Ahn K, Kember RL et al.

36882501 PubMed ID
GWAS Study Type
1672 Participants
279 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HE
Humphries EM
AK
Ahn K
KR
Kember RL
LF
Lopes FL
ME
Mocci E
PJ
Peralta JM
BJ
Blangero J
GD
Glahn DC
GF
Goes FS
ZP
Zandi PP
KP
Kochunov P
VH
Van Hout C
SA
Shuldiner AR
PT
Pollin TI
MB
Mitchell BD
BM
Bucan M
HL
Hong LE
MF
McMahon FJ
AS
Ament SA
Chapter II

Abstract

Summary of the research findings

Genome-wide association studies (GWAS) of mood disorders in large case-control cohorts have identified numerous risk loci, yet pathophysiological mechanisms remain elusive, primarily due to the very small effects of common variants. We sought to discover risk variants with larger effects by conducting a genome-wide association study of mood disorders in a founder population, the Old Order Amish (OOA, n = 1,672). Our analysis revealed four genome-wide significant risk loci, all of which were associated with >2-fold relative risk. Quantitative behavioral and neurocognitive assessments (n = 314) revealed effects of risk variants on sub-clinical depressive symptoms and information processing speed. Network analysis suggested that OOA-specific risk loci harbor novel risk-associated genes that interact with known neuropsychiatry-associated genes via gene interaction networks. Annotation of the variants at these risk loci revealed population-enriched, non-synonymous variants in two genes encoding neurodevelopmental transcription factors, CUX1 and CNOT1. Our findings provide insight into the genetic architecture of mood disorders and a substrate for mechanistic and clinical studies.

1,672 Old Order Amish (founder/genetic isolate) ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

1672
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.